MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
about
Neuroendocrine differentiation and the ubiquitin-proteasome system in cancer: Partners or enemies?Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine TumoursChrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.The molecular pathogenesis and management of bronchial carcinoids.Translation of molecular pathways into clinical trials of neuroendocrine tumors.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.
P2860
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
@en
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
@nl
type
label
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
@en
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
@nl
prefLabel
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
@en
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
@nl
P2093
P2860
P1476
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
@en
P2093
Herbert Chen
Jui-yu Chen
Mackenzie R Cook
Muthusamy Kunnimalaiyaan
Scott N Pinchot
P2860
P356
10.1016/J.JSS.2009.05.032
P577
2010-01-01T00:00:00Z